Dupert offers new hope for advanced NSCLC patients as China’s first KRAS G12C Inhibitor: GlobalData EP News Bureau Sep 9, 2024 GlobalData highlights Dupert’s role in addressing the growing KRAS G12C mutation burden in China’s advanced NSCLC treatment…
